Bevacizumab Injection
Bevacizumab, an anti-vascular endothelial growth factor monoclonal antibody (anti-VEGF mAb)
Fully humanized monoclonal antibody biosimilar as a broad-spectrum antitumor drug
Bevacizumab（Arketin）, an anti-vascular endothelial growth factor monoclonal antibody (anti-VEGF mAb), specifi_x005fcally binds to VEGF to prevent VEGF from binding to its receptor, thereby reducing neovascularization, inducing degeneration of existing blood vessels and inhibiting tumor growth. As a broad-spectrum anti-tumor agent, bevacizumab is a standard regimen recommended in treatment guidelines for various malig_x0002_nancies worldwide. Since entering the market, its efficacy and safety have been widely demonstrated in clinical practice.
Indications
Metastatic colorectal cancer; advanced, metastatic, or recurrent non-small cell lung cancer; recurrent glioblastoma; epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer; and cervical cancer.
Recommended reading
How to choose a suitable bevacizumab biosimilar manufacturer?
Related products
-
-
7000A 12V&24V Jump Starter for Truck Starting in -40C
Contact Us（*For Jump Starter ODM/OEM Solutions, secure your exclusive quotation now!）
-
-
Pomegranate Powder Extract (Hull) Ellagic Acid
Contact UsLatin Name: Punica granatum L
Synonyms:
Part of Used: Hull
Specifications: Ellagic Acid 80% HPLC
Appearance:
Application:Food Supplements/Nutritional Supplement/Functional Food/Pharmaceutical
Reviews
There are no reviews yet.